Abstract:Summary: Sleep is a modulator of seizure activity, and many antiepileptic drugs are modulators of sleep. Can influences on sleep organization be involved in antiepileptic drug action, and can these partly account for differences in drug response of various epileptic syndromes? Much more exact data must be collected before these questions can be adequately discussed. The polygraphic sleep of 40 unmedicated epileptic patients was recorded and compared with polygraphy after adjustment to therapeutic steady states of phenobarbital (PB) and phenytoin (DPH) (as sequential sole agents in a crossover design with random sequence). With PB, patients fell asleep more rapidly and had fewer movements, movement arousals, and arousal awakenings, all of which could be beneficial, especially for patients with generalized epilepsy. Light sleep was increased, and REM sleep decreased. The usual sleep pattern was altered, with maximal deep sleep early and maximal REM sleep late in the night. PB seemed to have maximal effect in the first REM cycle. With DPH, sleep onset also came sooner, but light sleep was decreased and deep sleep increased, with no alteration of REM sleep. In contrast to PB, the changes in sleep organization were toward leveling the distribution of deep NREM sleep. The maximal alterations were observed in the third REM cycle. With both drugs, there were some differences in the response of generalized as opposed to focal epilepsies, and of awakening as opposed to sleep epilepsies. Thus, the early REM cycles seemed to be more modifiable by drugs in patients with generalized or awakening epilepsies than in patients with focal or sleep epilepsies. The changes observed in photosensitive patients differed from those observed in nonpho‐tosensitive patients with generalized epilepsy, and there was some indication that, in photosensitive subjects, stage 2 was particularly susceptible to change. Group differences were not explained by differences of serum drug levels. The extent of adaptation to the drugs that might be reflected in some of the findings cannot yet be estimated. Thus it appears that the data provided by this first prospective study on antiepileptic drugs and sleep based on unmedicated patients give rise to new hypotheses and call for further study by longitudinal investigations.

Determination of Berberine Hydrochloride and Palmatine Hydrochloride in Coptis omeiensis and Coptis deltoidea

Analysis of Contents of Berberine in Coptis Chinensis of Lichuan

[Quality Analysis and Evaluation of Rhizoma Coptidis under Different Cultivation Conditions].

Species evolution and quality evaluation of four Coptis herbal medicinal materials in Southwest China

Determination of Protoberberine Alkaloids in Coptis chinensis by Microextraction and High Performance Liquid Chromatography

Integration of HPLC-based fingerprint and quantitative analyses for differentiating botanical species and geographical growing origins of Rhizoma coptidis

Comprehensive analyses of molecular phylogeny and main alkaloids for Coptis (Ranunculaceae) species identification

Chemical profiling of Coptis rootlet and screening of its bioactive compounds in inhibiting Staphylococcus aureus by UPLC-Q-TOF/MS

[Analysis and Assessment of Coptis Chinensis for Different Parts, Ages, and Heights Using Fourier Transform Infrared Spectroscopy].

Influence of Therapeutic Phenobarbital and Phenytoin Medication on the Polygraphic Sleep of Patients with Epilepsy

Comparative studies on Ophiopogonis and Liriopes based on the determination of 11 bioactive components using LC–MS/MS and Hierarchical clustering analysis

Scientometric Analysis of Medicinal and Edible Plant Coptis

Analysis of alkaloids in Coptis chinensis Franch by accelerated solvent extraction combined with ultra performance liquid chromatographic analysis with photodiode array and tandem mass spectrometry detections

Berberine: Production Through Plant (Thalictrum spp.) Cell Cultures

Effective Extraction of Palmatine and Berberine from Coptis chinensis by Deep Eutectic Solvents-Based Ultrasound-Assisted Extraction

The localization of the alkaloids in Coptis chinensis rhizome by time-of-flight secondary ion mass spectrometry

Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity

Investigation on the Antibacterial Activity of Coptis chinensis Franch and Its Components Compatibility by Microcalorimetry

Biological Response Profiling Reveals the Functional Differences of Main Alkaloids in Rhizoma Coptidis

Rapid and simultaneous determination of moisture and berberine content in Coptidis Rhizoma and Phellodendri Chinensis Cortex by near-infrared spectroscopy and chemometrics

Simultaneous Determination of Four Alkaloids in Coptis Teeta Wall